Identification of a serotonin/glutamate receptor complex implicated in psychosis J González-Maeso, RL Ang, T Yuen, P Chan, NV Weisstaub, ... Nature 452 (7183), 93-97, 2008 | 957 | 2008 |
Heterotrimeric G‐proteins: a short history G Milligan, E Kostenis British journal of pharmacology 147 (S1), S46-S55, 2006 | 779 | 2006 |
Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1–A2A receptor heteromers F Ciruela, V Casadó, RJ Rodrigues, R Luján, J Burgueno, M Canals, ... Journal of Neuroscience 26 (7), 2080-2087, 2006 | 726 | 2006 |
G protein–coupled receptor oligomerization revisited: functional and pharmacological perspectives S Ferré, V Casadó, LA Devi, M Filizola, R Jockers, MJ Lohse, G Milligan, ... Pharmacological reviews 66 (2), 413-434, 2014 | 618 | 2014 |
Tailoring cAMP-signalling responses through isoform multiplicity MD Houslay, G Milligan Trends in biochemical sciences 22 (6), 217-224, 1997 | 602 | 1997 |
G protein-coupled receptor dimerization: function and ligand pharmacology G Milligan Molecular pharmacology 66 (1), 1-7, 2004 | 567 | 2004 |
G-protein–coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor E Kostenis, G Milligan, A Christopoulos, CF Sanchez-Ferrer, ... Circulation 111 (14), 1806-1813, 2005 | 552 | 2005 |
Building a new conceptual framework for receptor heteromers S Ferré, R Baler, M Bouvier, MG Caron, LA Devi, T Durroux, K Fuxe, ... Nature chemical biology 5 (3), 131-134, 2009 | 487 | 2009 |
Antibodies directed against synthetic peptides distinguish between GTP-binding proteins in neutrophil and brain. P Goldsmith, P Gierschik, G Milligan, CG Unson, R Vinitsky, HL Malech, ... Journal of Biological Chemistry 262 (30), 14683-14688, 1987 | 414 | 1987 |
The dynamic role of palmitoylation in signal transduction G Milligan, M Parenti, AI Magee Trends in biochemical sciences 20 (5), 181-186, 1995 | 382 | 1995 |
International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1,-2, and-3: pharmacology and pathophysiological functions LA Stoddart, NJ Smith, G Milligan Pharmacological reviews 60 (4), 405-417, 2008 | 381 | 2008 |
The experimental power of FR900359 to study Gq-regulated biological processes R Schrage, AL Schmitz, E Gaffal, S Annala, S Kehraus, D Wenzel, ... Nature communications 6 (1), 10156, 2015 | 380 | 2015 |
G protein‐coupled receptor hetero‐dimerization: contribution to pharmacology and function G Milligan British journal of pharmacology 158 (1), 5-14, 2009 | 368 | 2009 |
Inverse agonism: pharmacological curiosity or potential therapeutic strategy? G Milligan, RA Bond, M Lee Trends in pharmacological sciences 16 (1), 10-13, 1995 | 360 | 1995 |
δ-opioid-receptor-mediated inhibition of adenylate cyclase is transduced specifically by the guanine-nucleotide-binding protein Gi2 FR McKenzie, G Milligan Biochemical Journal 267 (2), 391-398, 1990 | 351 | 1990 |
Techniques used in the identification and analysis of function of pertussis toxin-sensitive guanine nucleotide binding proteins. G Milligan Biochemical Journal 255 (1), 1, 1988 | 344 | 1988 |
Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective G Milligan Molecular pharmacology 64 (6), 1271-1276, 2003 | 343 | 2003 |
Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer: the human δ-opioid receptor … M McVey, D Ramsay, E Kellett, S Rees, S Wilson, AJ Pope, G Milligan Journal of Biological Chemistry 276 (17), 14092-14099, 2001 | 343 | 2001 |
International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers JP Pin, R Neubig, M Bouvier, L Devi, M Filizola, JA Javitch, MJ Lohse, ... Pharmacological reviews 59 (1), 5-13, 2007 | 337 | 2007 |
Allostery at G protein-coupled receptor homo-and heteromers: uncharted pharmacological landscapes NJ Smith, G Milligan, D Sibley Pharmacological reviews 62 (4), 701-725, 2010 | 321 | 2010 |